Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial
Arthritis & Rheumatism, 11/06/09
Koffeman EC et al. – Tolerization to dnaJP1 leads to immune deviation and a trend toward clinical efficacy. Susceptibility to treatment relies on the coexpression of molecules that can down-regulate adaptive immunity.
Methods- Pilot phase II trial
- 160 patients with active RA and immunologic reactivity to dnaJP1
- dnaJP1 peptide safe and well-tolerated
- Significant reduction in percentage of T cells producing tumor necrosis factor and corresponding trend toward increased percentage of T cells producing interleukin-10
- Coexpression of cluster of molecules (programmed death 1 and its ligands) associated with T cell regulation also found to be a prerequisite for successful tolerization in clinical responders
- Analysis of primary efficacy end point (meeting the American College of Rheumatology 20% improvement criteria at least once on day 112, 140, or 168) showed difference between treatment groups that became significant in post hoc analysis using generalized estimating equations
- Differences in clinical responses also found between treatment groups on day 140 and followup
- Post hoc analysis showed that combination of dnaJP1 and hydroxychloroquine (HCQ) was superior to combination of HCQ and placebo
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Primary Care Providers Views of Challenges and Rewards of Dementia Care Relative to Other Conditions
Journal of the American Geriatrics Society, 11/24/09
Pulmonary Rehabilitation: A Focus on COPD in Primary Care
Postgraduate Medicine, 11/24/09
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
Canadian Medical Association Journal, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


